Who owns REGNWhat REGN owns
What Regeneron Pharmaceuticals, Inc. owns
The company's own 13F portfolio · as of 2026-03-31 · long US-listed stakes only — private holdings, bonds and cash are not disclosable on a 13F
$47.9M
disclosed stock portfolio
2
positions
99.1%
in NTLA
Positions, as of 2026-03-31
ordered by filed value · % of book = share of the disclosed stock portfolio · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | NTLAIntellia Therapeutics, Inc. | 3.7M | $47.5M | 99.1% |
| 2 | Adicet Bio, Inc. | 60,511 | $412,080 | 0.9% |
Source: SEC Form 13F-HR filed by REGENERON PHARMACEUTICALS, INC. (CIK 872589), reporting period 2026-03-31. Values are quarter-end filed marks. Research, not investment advice.